PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
